Screening of world approved drugs against highly dynamical spike glycoprotein of SARS-CoV-2 using CaverDock and machine learning

The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes pathological pulmonary symptoms. Most efforts to develop vaccines and drugs against this virus target the spike glycoprotein, particularly its S1 subunit, which is recognised by angiotensin-converting enzyme 2. Here we use t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Gaspar P., Vavra, Ondrej, Marques, Sergio M., Filipovic, Jiri, Bednar, David, Damborsky, Jiri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174816/
https://www.ncbi.nlm.nih.gov/pubmed/34104357
http://dx.doi.org/10.1016/j.csbj.2021.05.043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174816/
https://www.ncbi.nlm.nih.gov/pubmed/34104357
http://dx.doi.org/10.1016/j.csbj.2021.05.043

Ejemplares similares